- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2012
- Public Summary Document (PSD) March 2012 PBAC Meeting - PDF
Velaglucerase alfa – March 2012
Velaglucerase alfa, powder for IV infusion, 400 units in 4 mL, VPRIV® - March 2012
Last updated
8 November 2023
